Three months ended December 31, Year ended December 31, 2025 2024 2025 2024 Net sales $ 6,133 $ 6,010 $ 24,948 $ 24,575 Operating expenses Cost of sales 4,075 3,744 14,991 14,447 Selling, general and administrative expenses 965 899 3,997 4,221 Research, development and related expenses 299 282 1,169 1,085 (Gain) loss on business divestitures (2) — 162 — Total operating expenses 5,337 4,925 20,319 19,753 Operating income 796 1,085 4,629 4,822 Other expense (income), net 38 326 416 3 Income from continuing operations before income taxes 758 759 4,213 4,819 Provision for income taxes 185 33 1,003 804 Income from continuing operations of consolidated group 573 726 3,210 4,015 Income from unconsolidated subsidiaries, net of taxes 1 2 52 9 Net income from continuing operations including noncontrolling interest 574 728 3,262 4,024 Less: net income (loss) attributable to noncontrolling interest (3) — 12 15 Net income from continuing operations attributable to 3M 577 728 3,250 4,009 Net income from discontinued operations, net of taxes — — — 164 Net income attributable to 3M $ 577 $ 728 $ 3,250 $ 4,173 Earnings per share attributable to 3M common shareholders: Weighted average 3M common shares outstanding — basic 534.3 543.6 537.4 550.8 Earnings per share from continuing operations — basic $ 1.08 $ 1.34 $ 6.05 $ 7.28 Earnings per share from discontinued operations — basic — — — 0.30 Earnings per share — basic $ 1.08 $ 1.34 $ 6.05 $ 7.58 Weighted average 3M common shares outstanding — diluted 539.0 546.3 541.3 552.4 Earnings per share from continuing operations — diluted $ 1.07 $ 1.33 $ 6.00 $ 7.26 Earnings per share from discontinued operations — diluted — — — 0.29 Earnings per share — diluted $ 1.07 $ 1.33 $ 6.00 $ 7.55 3M Company and Subsidiaries CONSOLIDATED STATEMENT OF INCOME (Millions, except per-share amounts) (Unaudited) 1 -- 1 of 15 -- December 31, 2025 December 31, 2024 Assets Current assets Cash and cash equivalents $ 5,235 $ 5,600 Marketable securities 698 2,128 Accounts receivable – net 3,533 3,194 Inventories 3,661 3,698 Prepaids 391 493 Assets held for sale 46 — Other current assets 2,823 771 Total current assets 16,387 15,884 Property, plant and equipment – net 7,101 7,388 Operating lease right of use assets 516 565 Goodwill and intangible assets – net 7,522 7,491 Other assets 6,207 8,540 Total assets $ 37,733 $ 39,868 Liabilities and equity Current liabilities Short-term borrowings and current portion of long-term debt $ 1,670 $ 1,919 Accounts payable 2,702 2,660 Accrued payroll 718 712 Operating lease liabilities 167 163 Liabilities held for sale 55 — Other current liabilities 4,283 5,802 Total current liabilities 9,595 11,256 Long-term debt 10,932 11,125 Other liabilities 12,459 13,593 Total liabilities 32,986 35,974 Total equity 4,747 3,894 Shares outstanding December 31, 2025: 530,279,131 December 31, 2024: 539,470,303 Total liabilities and equity $ 37,733 $ 39,868 3M Company and Subsidiaries CONDENSED CONSOLIDATED BALANCE SHEET (Dollars in millions) (Unaudited) 2 -- 2 of 15 -- Year ended December 31, 2025 2024 Net cash provided by (used in) operating activities $ 2,306 $ 1,819 Cash flows from investing activities: Purchases of property, plant and equipment (910) (1,181) Purchases and proceeds from sale or maturities of marketable securities and investments – net 2,163 (2,079) Other investing activities 97 54 Net cash provided by (used in) investing activities 1,350 (3,206) Cash flows from financing activities: Change in debt – net (716) 5,506 Purchases of treasury stock and dividends paid to shareholders (4,813) (3,783) Proceeds from issuances of treasury stock pursuant to stock option and benefit plans 1,562 92 Cash transferred to Solventum related to separation, net — (621) Other financing activities (49) (96) Net cash provided by (used in) financing activities (4,016) 1,098 Effect of exchange rate changes on cash and cash equivalents 41 (44) Net increase (decrease) in cash and cash equivalents, including cash classified within assets held for sale (319) (333) Less: net increase (decrease) in cash classified within assets held for sale 46 — Net increase (decrease) in cash and cash equivalents (365) (333) Cash and cash equivalents at beginning of year 5,600 5,933 Cash and cash equivalents at end of period $ 5,235 $ 5,600 The Consolidated Statements of Cash Flows include the results of continuing and discontinued operations and, therefore, also include cash and cash equivalents associated with Solventum through its April 2024 separation from 3M that were presented in current assets of discontinued operations in the 3M Consolidated Balance Sheet. 3M Company and Subsidiaries CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Dollars in millions) (Unaudited) 3 -- 3 of 15 -- Three months ended December 31, 2025 By reportable business segment Organic sales Divestitures Translation Total sales change Safety and Industrial 3.8 % — % 2.2 % 6.0 % Transportation and Electronics (2.5) (0.2) 1.0 (1.7) Consumer (2.2) — 1.0 (1.2) Total reportable business segments 0.4 (0.1) 1.6 1.9 Total Company 0.6 (0.1) 1.6 2.1 By geographic area Americas 0.1 % (0.1) % 0.5 % 0.5 % China (1.9) — 1.1 (0.8) Other Asia 5.0 — (1.2) 3.8 Europe, Middle East and Africa (0.6) — 7.8 7.2 Year ended December 31, 2025 By reportable business segment Organic sales Divestitures Translation Total sales change Safety and Industrial 3.2 % — % 0.7 % 3.9 % Transportation and Electronics (1.5) (0.1) 0.3 (1.3) Consumer (0.3) — 0.1 (0.2) Total reportable business segments 0.9 — 0.4 1.3 Total Company 0.9 0.2 0.4 1.5 By geographic area Americas 1.3 % 0.3 % (0.3) % 1.3 % China 4.3 0.1 0.1 4.5 Other Asia (0.1) — (0.6) (0.7) Europe, Middle East and Africa (1.7) 0.2 3.9 2.4 2Total sales change is calculated based on reported sales results. The components of sales change include organic local-currency sales, acquisitions, divestitures, and translation. Organic local-currency sales include both organic volume impacts (which excludes acquisition and divestiture impacts) and selling price changes. Acquisition and divestiture impacts are measured separately for the first 12 months post-transaction and, beginning April 2024, include the impact of commercial agreements associated with the separation of Solventum. 3M Company and Subsidiaries SALES CHANGE ANALYSIS2 (Unaudited) 4 -- 4 of 15 -- 3M discloses business segment operating income as its measure of segment profit, reconciled to both total 3M operating income and income before taxes. Business segment operating income excludes certain expenses and income that are not allocated to business segments (as described below in “Corporate and Other”). Three months ended December 31, Year ended December 31, Net sales (millions) 2025 2024 2025 2024 Abrasives $ 341 $ 320 $ 1,340 $ 1,295 Automotive Aftermarket 304 312 1,178 1,235 Electrical Markets 347 322 1,394 1,274 Industrial Adhesives and Tapes 568 513 2,266 2,104 Industrial Specialties Division 293 288 1,172 1,161 Personal Safety 917 829 3,544 3,371 Roofing Granules 95 119 490 521 Total Safety and Industrial business segment 2,865 2,703 11,384 10,961 Advanced Materials 187 218 858 969 Automotive and Aerospace 468 456 1,901 1,912 Commercial Branding and Transportation 606 587 2,602 2,528 Electronics 700 733 2,911 2,971 Total Transportation and Electronics business segment 1,961 1,994 8,272 8,380 Consumer Safety and Well-Being 260 249 1,108 1,080 Home and Auto Care 291 293 1,200 1,191 Home Improvement 369 371 1,486 1,486 Packaging and Expression 294 316 1,126 1,174 Total Consumer business segment 1,214 1,229 4,920 4,931 Total reportable business segments 6,040 5,926 24,576 24,272 Corporate and Other 93 84 372 303 Total company $ 6,133 $ 6,010 $ 24,948 $ 24,575 Operating income (millions) Safety and Industrial $ 665 $ 572 $ 2,836 $ 2,491 Transportation and Electronics 140 233 1,436 1,578 Consumer 218 234 996 932 Total reportable business segments 1,023 1,039 5,268 5,001 Corporate and Other Corporate-level (expense) income (14) (5) 75 (114) Corporate special items: Net costs for significant litigation (160) 51 (483) (45) Divestiture costs — — — (20) Gain (loss) on business divestitures 2 — (162) — Transformation costs (55) — (69) — Total Corporate and Other (227) 46 (639) (179) Total company operating income 796 1,085 4,629 4,822 Other expense/(income), net 38 326 416 3 Income from continuing operations before income taxes $ 758 $ 759 $ 4,213 $ 4,819 3M Company and Subsidiaries BUSINESS SEGMENTS (Unaudited) 5 -- 5 of 15 -- Corporate and Other Outside of 3M's reportable segments, 3M has Corporate and Other which is not a reportable business segment as it does not meet the segment reporting criteria. Because Corporate and Other includes a variety of miscellaneous items, it is subject to fluctuation on a quarterly and annual basis. Corporate and Other operating income (loss) includes: • Corporate-level (expense) income includes: ◦ certain enterprise and governance activities resulting in unallocated corporate costs and other activity or costs that 3M may choose not to allocate directly to its business segments, ◦ commercial activity with Solventum following its April 1, 2024 Separation and certain operations of the former Health Care business segment retained by 3M, ◦ transition arrangement agreements (e.g., fees charged by 3M, net of underlying costs) related to divested businesses, including those related to the Solventum Separation, ◦ operations of businesses of the former Health Care segment divested prior to the Separation and therefore not reflected as discontinued operations within 3M's financial statements, along with limited-duration supply agreements with previous divestitures, and ◦ costs previously allocated to Solventum prior to the Separation that were not eligible to be part of discontinued operations. • Corporate special items include, for the periods presented: ◦ net costs for significant litigation impacting operating income (loss) associated with PFAS-related other environmental and Combat Arms Earplugs matters, ◦ gain (loss) on business divestitures, ◦ divestiture costs (related to separating and divesting substantially an entire business segment of 3M following public announcement of its intended divestiture) that were not eligible to be part of discontinued operations, and ◦ transformation program restructuring and related charges. 3M Company and Subsidiaries BUSINESS SEGMENTS - (CONTINUED) (Unaudited) 6 -- 6 of 15 -- In addition to reporting financial results in accordance with U.S. GAAP, 3M also provides certain non-GAAP measures. These measures are not in accordance with, nor are they a substitute for GAAP measures, and may not be comparable to similarly titled measures used by other companies. Certain measures adjust for the impacts of special items. Special items for the periods presented include the items described in the section entitled “Description of special items”. Because 3M provides certain information with respect to business segments, it is noteworthy that special items impacting operating income (loss) are reflected in Corporate and Other, except as described with respect to net costs for significant litigation and manufactured PFAS products items in the “Description of special items” section. The reconciliations below, therefore, also include impacted segments as applicable. This document contains measures for which 3M provides the reported GAAP measure and a non-GAAP measure adjusted for special items. The document also contains additional measures which are not defined under U.S. GAAP. These measures and reasons 3M believes they are useful to investors (and, as applicable, used by 3M) include: GAAP amounts for which a measure adjusted for special items is also provided: Reasons 3M believes the measure is useful: • Net sales (and sales change) Considered, in addition to segment operating performance, in evaluating and managing operations; useful in understanding underlying business performance, provides additional transparency to special items • Operating income (loss), total reportable segment operating income, segment operating income (loss) and operating income (loss) margin (and expansion) • Income from continuing operations before taxes • Provision for income taxes and effective tax rate • Net income from continuing operations • EPS from continuing operations Additional non-GAAP measures: • Adjusted net cash provided by (used in) operating activities; adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures); adjusted free cash flow and adjusted free cash flow conversion Used as indicators of strength and ability to generate cash and as indicator of capital deployment; meaningful as measures of performance The following provides additional information and applicable GAAP amounts reconciled to non-GAAP measures. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (Unaudited) 7 -- 7 of 15 -- Certain amounts adjusted for special items (non-GAAP measures): Three months ended December 31, 2024 Amounts from continuing operations (Dollars in millions, except per share amounts) Net sales Operating income Operating income margin Income before taxes Provision for income taxes Effective tax rate Net income attributable to 3M EPS Safety and Industrial GAAP amounts $ 572 21.2 % Adjustments for special items: Net costs for significant litigation (4) Adjusted amounts (non-GAAP measures)3 $ 568 21.0 % Transportation and Electronics GAAP amounts $ 1,994 $ 233 11.7 % Adjustments for special items: Manufactured PFAS products (202) 114 Adjusted amounts (non-GAAP measures)3 $ 1,792 $ 347 19.4 % Total reportable business segments GAAP amounts $ 5,926 $ 1,039 17.5 % Adjustments for special items: Net costs for significant litigation — (4) Manufactured PFAS products (202) 114 Adjusted amounts (non-GAAP measures)3 $ 5,724 $ 1,149 20.1 % Total company GAAP amounts $ 6,010 $ 1,085 18.1 % $ 759 $ 33 4.2 % $ 728 $ 1.33 Adjustments for special items: Net costs for significant litigation — (55) 101 137 (36) (0.07) Manufactured PFAS products (202) 114 114 27 87 0.16 Pension risk transfer charge — — 13 3 10 0.02 Solventum ownership - change in value — — 130 — 130 0.24 Total special items (202) 59 358 167 191 0.35 Adjusted amounts (non-GAAP measures)3 $ 5,808 $ 1,144 19.7 % $ 1,117 $ 200 17.9 % $ 919 $ 1.68 Three months ended December 31, 2025 Amounts from continuing operations (Dollars in millions, except per share amounts) Net sales Sales change Operating income Operating income margin Operating income margin expansion Income before taxes Provision for income taxes Effective tax rate Net income attributable to 3M EPS EPS percent change Safety and Industrial GAAP amounts $ 665 23.2 % Adjustments for special items: Net costs for significant litigation 25 Adjusted amounts (non-GAAP measures)3 $ 690 24.1 % Transportation and Electronics GAAP amounts $ 1,961 (1.7) % $ 140 7.2 % Adjustments for special items: Manufactured PFAS products (110) 235 Adjusted amounts (non-GAAP measures)3 $ 1,851 3.3 % $ 375 20.3 % Total reportable business segments GAAP amounts $ 6,040 1.9 % $ 1,023 16.9 % Adjustments for special items: Net costs for significant litigation — 25 Manufactured PFAS products (110) 235 Adjusted amounts (non-GAAP measures)3 $ 5,930 3.6 % $ 1,283 21.6 % Total company GAAP amounts $ 6,133 2.1 % $ 796 13.0 % (510) bps $ 758 $ 185 24.5 % $ 577 $ 1.07 (20) % Adjustments for special items: Net costs for significant litigation — 185 310 10 300 0.56 Loss on business divestitures — (2) (2) — (2) — Manufactured PFAS products (110) 235 235 22 213 0.39 Solventum ownership - change in value — — (160) — (160) (0.30) Transformation costs — 55 55 (4) 59 0.11 Total special items (110) 473 438 28 410 0.76 Adjusted amounts (non-GAAP measures)3 $ 6,023 3.7 % $ 1,269 21.1 % 140 bps $ 1,196 $ 213 17.7 % $ 987 $ 1.83 9 % 3These items represent amounts adjusted for special items. See lead-in to non-GAAP measures discussion. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES – (CONTINUED) (Unaudited) 8 -- 8 of 15 -- Year ended December 31, 2024 Amounts from continuing operations (Dollars in millions, except per share amounts) Net sales Operating income Operating income margin Income before taxes Provision for income taxes Effective tax rate Net income attributable to 3M EPS Safety and Industrial GAAP amounts $ 2,491 22.7 % Adjustments for special items: Net costs for significant litigation 36 Adjusted amounts (non-GAAP measures)3 $ 2,527 23.1 % Transportation and Electronics GAAP amounts $ 8,380 $ 1,578 18.8 % Adjustments for special items: Manufactured PFAS products (945) 144 Adjusted amounts (non-GAAP measures)3 $ 7,435 $ 1,722 23.2 % Total reportable business segments GAAP amounts $ 24,272 $ 5,001 20.6 % Adjustments for special items: Net costs for significant litigation — 36 Manufactured PFAS products (945) 144 Adjusted amounts (non-GAAP measures)3 $ 23,327 $ 5,181 22.2 % Total Company GAAP amounts $ 24,575 $ 4,822 19.6 % $ 4,819 $ 804 16.7 % $ 4,009 $ 7.26 Adjustments for special items: Net costs for significant litigation — 81 800 68 732 1.32 Divestiture costs — 20 20 (111) 131 0.24 Manufactured PFAS products (945) 144 144 34 110 0.20 Pension risk transfer charge — — 808 191 617 1.11 Solventum ownership - change in value — — (1,564) — (1,564) (2.83) Total special items (945) 245 208 182 26 0.04 Adjusted amounts (non-GAAP measures)3 $ 23,630 $ 5,067 21.4 % $ 5,027 $ 986 19.6 % $ 4,035 $ 7.30 Year ended December 31, 2025 Amounts from continuing operations (Dollars in millions, except per share amounts) Net sales Sales change Operating income Operating income margin Operating income margin expansion Income before taxes Provision for income taxes Effective tax rate Net income attributable to 3M EPS EPS percent change Safety and Industrial GAAP amounts $ 2,836 24.9 % Adjustments for special items: Net costs for significant litigation 58 Adjusted amounts (non-GAAP measures)3 $ 2,894 25.4 % Transportation and Electronics GAAP amounts $ 8,272 (1.3) % $ 1,436 17.4 % Adjustments for special items: Manufactured PFAS products (669) 292 Adjusted amounts (non-GAAP measures)3 $ 7,603 2.3 % $ 1,728 22.7 % Total reportable business segments GAAP amounts $ 24,576 1.3 % $ 5,268 21.4 % Adjustments for special items: Net costs for significant litigation — 58 Manufactured PFAS products (669) 292 Adjusted amounts (non-GAAP measures)3 $ 23,907 2.5 % $ 5,618 23.5 % Total Company GAAP amounts $ 24,948 1.5 % $ 4,629 18.6 % (100) bps $ 4,213 $ 1,003 23.8 % $ 3,250 $ 6.00 (17) % Adjustments for special items: Net costs for significant litigation — 541 1,061 9 1,052 1.95 Loss on business divestitures — 162 162 3 159 0.29 Manufactured PFAS products (669) 292 292 36 256 0.47 Solventum ownership - change in value — — (402) 23 (425) (0.78) Transformation costs — 69 69 (1) 70 0.13 Total special items (669) 1,064 1,182 70 1,112 2.06 Adjusted amounts (non-GAAP measures)3 $ 24,279 2.7 % $ 5,693 23.4 % 200 bps $ 5,395 $ 1,073 19.9 % $ 4,362 $ 8.06 10 % 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES – (CONTINUED) (Unaudited) 9 -- 9 of 15 -- 2026 forecast 2026 adjusted operating income margin expansion (non-GAAP measure)3,4 70 bps to 80 bps 2026 adjusted earnings per share from continuing operations (non-GAAP measure)3,4 $8.50 to $8.70 2026 adjusted effective tax rate (non-GAAP measure)3,4 ~20% 43M provides these forward-looking non-GAAP measures, but cannot, without unreasonable effort, forecast certain items to present or provide a reconciliation to corresponding forecasted GAAP measures. These include special items such as net costs for significant litigation; projected divestiture gains (losses); divestiture costs; divestiture-related restructuring; changes in value of Solventum ownership; transformation costs; and net sales and estimates of income and associated activity of exited manufactured PFAS products all of which are subject to limitations in predictability of timing, ultimate outcome and numerous conditions outside of 3M’s control. 3M believes these limitations would result in a range of projected values so broad as to not be meaningful to investors. For these reasons, 3M believes that the probable significance of such information is low. Additionally, for similar reasons, 3M does not include the impact of potentially-divested or acquired businesses on expected operations in forecasted guidance it provides until close of a transaction. Information with respect to special items for certain historical periods is included in the section entitled “Description of special items”. Three months ended December 31, 2025 Sales change2 Organic sales Divestitures Translation Total sales change Total company 0.6 % (0.1) % 1.6 % 2.1 % Remove manufactured PFAS products special item impact 1.6 — — 1.6 Adjusted total company (non-GAAP measures)3 2.2 % (0.1) % 1.6 % 3.7 % Total reportable business segments 0.4 % (0.1) % 1.6 % 1.9 % Remove manufactured PFAS products special item impact 1.6 — 0.1 1.7 Adjusted total reportable business segments (non-GAAP measures)3 2.0 % (0.1) % 1.7 % 3.6 % Transportation and Electronics (2.5) % (0.2) % 1.0 % (1.7) % Remove manufactured PFAS products special item impact 4.9 (0.1) 0.2 5.0 Adjusted Transportation and Electronics (non-GAAP measures)3 2.4 % (0.3) % 1.2 % 3.3 % Six months ended June 30, 2025 Sales change2 Organic sales Divestitures Translation Total sales change Total Company 0.2 % 0.5 % (0.5) % 0.2 % Remove manufactured PFAS products special item impact 1.3 — 0.1 1.4 Adjusted total Company (non-GAAP measures)3 1.5 % 0.5 % (0.4) % 1.6 % Transportation and Electronics (2.8) % — % (0.2) % (3.0) % Remove manufactured PFAS products special item impact 3.8 — — 3.8 Adjusted Transportation and Electronics (non-GAAP measures)3 1.0 % — % (0.2) % 0.8 % Six months ended December 31, 2025 Sales change2 Organic sales Divestitures Translation Total sales change Total Company 1.6 % (0.1) % 1.3 % 2.8 % Remove manufactured PFAS products special item impact 1.1 — — 1.1 Adjusted total Company (non-GAAP measures)3 2.7 % (0.1) % 1.3 % 3.9 % Transportation and Electronics (0.3) % (0.2) % 1.0 % 0.5 % Remove manufactured PFAS products special item impact 3.3 (0.1) — 3.2 Adjusted Transportation and Electronics (non-GAAP measures)3 3.0 % (0.3) % 1.0 % 3.7 % 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES – (CONTINUED) (Unaudited) 10 -- 10 of 15 -- Year ended December 31, 2025 Sales change2 Organic sales Divestitures Translation Total sales change Total Company 0.9 % 0.2 % 0.4 % 1.5 % Remove manufactured PFAS products special item impact 1.2 — — 1.2 Adjusted total Company (non-GAAP measures)3 2.1 % 0.2 % 0.4 % 2.7 % Total reportable business segments 0.9 % — % 0.4 % 1.3 % Remove manufactured PFAS products special item impact 1.2 (0.1) 0.1 1.2 Adjusted total reportable business segments (non-GAAP measures)3 2.1 % (0.1) % 0.5 % 2.5 % Transportation and Electronics (1.5) % (0.1) % 0.3 % (1.3) % Remove manufactured PFAS products special item impact 3.5 (0.1) 0.2 3.6 Adjusted Transportation and Electronics (non-GAAP measures)3 2.0 % (0.2) % 0.5 % 2.3 % By geographic area Americas 1.3 % 0.3 % (0.3) % 1.3 % Remove manufactured PFAS products special item impact 0.4 — — 0.4 Adjusted Americas (non-GAAP measures)3 1.7 % 0.3 % (0.3) % 1.7 % China 4.3 % 0.1 % 0.1 % 4.5 % Remove manufactured PFAS products special item impact 0.5 — — 0.5 Adjusted China (non-GAAP measures)3 4.8 % 0.1 % 0.1 % 5.0 % Other Asia (0.1) % — % (0.6) % (0.7) % Remove manufactured PFAS products special item impact 3.2 — — 3.2 Adjusted Other Asia (non-GAAP measures)3 3.1 % — % (0.6) % 2.5 % Europe, Middle East & Africa (1.7) % 0.2 % 3.9 % 2.4 % Remove manufactured PFAS products special item impact 2.4 — 0.1 2.5 Adjusted Europe, Middle East & Africa (non-GAAP measures)3 0.7 % 0.2 % 4.0 % 4.9 % By particular country United States 1.0 % 0.4 % — % 1.4 % Remove manufactured PFAS products special item impact 0.4 — — 0.4 Adjusted United States (non-GAAP measures)3 1.4 % 0.4 % — % 1.8 % 2026 forecast Sales Change2 Organic sales Acquisitions Divestitures Translation Total sales change Total Company4 ~3% — % — % ~1% ~4% Adjusted net cash provided by (used in) operating activities; adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures); adjusted free cash flow and adjusted free cash flow conversion (non- GAAP measures): Three months ended December 31, Year ended December 31, Major GAAP cash flow categories (dollars in millions) 2025 2024 2025 2024 Net cash provided by (used in) operating activities $ 1,583 $ 1,818 $ 2,306 $ 1,819 Net cash provided by (used in) investing activities (405) (1,146) 1,350 (3,206) Net cash provided by (used in) financing activities (617) (1,080) (4,016) 1,098 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES – (CONTINUED) (Unaudited) 11 -- 11 of 15 -- Three months ended December 31, Year ended December 31, Adjusted free cash flow (non-GAAP measure) (dollars in millions) 2025 2024 2025 2024 Net cash provided by (used in) operating activities $ 1,583 $ 1,818 $ 2,306 $ 1,819 Adjustments for special items: Net costs/(recoveries) for significant litigation after-tax payment impacts 14 (192) 2,817 3,831 Divestiture costs and divestiture-related restructuring after-tax payment impacts 17 44 102 374 TCJA transition tax payment — — 211 193 Transformation actions after-tax payment impacts 11 — 11 — Manufactured PFAS products after-tax payment impacts (91) (63) (183) (229) Total adjustments for special items (49) (211) 2,958 4,169 Adjusted net cash provided by (used in) operating activities (non-GAAP measure)5 $ 1,534 $ 1,607 $ 5,264 $ 5,988 Purchases of property, plant and equipment (PPE) (248) (291) (910) (1,181) Manufactured PFAS products impact - removing related purchases of PPE 5 17 20 70 Adjusted purchases of PPE (non-GAAP measure)5 $ (243) $ (274) $ (890) $ (1,111) Adjusted free cash flow (non-GAAP measure)5 $ 1,291 $ 1,333 $ 4,374 $ 4,877 Net income attributable to 3M $ 577 $ 728 $ 3,250 $ 4,173 Adjustments for special items, net of tax: Net costs for significant litigation 300 (36) 1,052 732 Manufactured PFAS products impact 213 87 256 110 Loss on business divestitures (2) — 159 — Divestiture costs — — — 341 Solventum ownership - change in value (160) 130 (425) (1,564) Pension risk transfer charge — 10 — 617 Transformation costs 59 — 70 — Total adjustments for special items, net of tax 410 191 1,112 236 Net income attributable to 3M adjusted for special items (used for adjusted free cash flow conversion calculation) $ 987 $ 919 $ 4,362 $ 4,409 Adjusted free cash flow conversion (non-GAAP measure)5 131 % 145 % 100 % 111 % 53M’s Consolidated Statements of Cash Flows include the results of continuing and discontinued operations (Solventum separated from 3M in April 2024); accordingly, amounts associated with the determination of adjusted free cash flow include both continuing and discontinued operations in certain periods both from an income and cash flow perspective. 3M defines adjusted net cash provided by (used in) operating activities as net cash provided by operating activities, adjusted for special items. 3M defines adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures) as purchases of property, plant and equipment (PPE) adjusted for the estimated impact of such purchases associated with manufactured PFAS products activity. 3M defines adjusted free cash flow as adjusted net cash provided by (used in) operating activities less adjusted purchases of PPE. Cash payments/receipts associated with special items in the determination of adjusted net cash provided by (used in) operating activities are reflected net of applicable tax. The cash tax impact for the portion of payments of costs for significant litigation under the 2023 and 2025 settlement/proposed settlement agreements relative to Combat Arms Earplugs and relative to public water suppliers and the state of New Jersey regarding PFAS is based on the timing/amount of the actual cash tax deduction (which differs from the timing of the pre-tax cash settlement payments). The impacts of certain tax-related divestiture costs are based on applicable tax rates and the timing of tax payments relative to underlying Separation transactions. For other special items, the cash tax impact is estimated using the U.S. statutory corporate tax rate during the period of payment/receipt. Tax impacts include associated impacts on Foreign Derived Intangible Income (FDII), Global Intangible Low Taxed Income (GILTI), foreign tax credits, and tax costs of repatriation. 3M defines adjusted free cash flow conversion as adjusted free cash flow divided by net income attributable to 3M, adjusted for special items (used for adjusted free cash flow conversion calculation). 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES – (CONTINUED) (Unaudited) 12 -- 12 of 15 -- (Dollars in billions) 2026 forecast Net cash provided by (used in) operating activities $5.6 to $5.8 Adjustments for special items4 — Adjusted net cash provided by (used in) operating activities (non-GAAP measure)4,5 $5.6 to $5.8 Purchase of property, plant and equipment (PPE) ~1.1 Adjusted free cash flow (non-GAAP measure)4,5 $4.6 to $4.8 Net income attributable to 3M $4.6 to $4.7 Adjustments for special items4 — Adjusted net income attributable to 3M (non-GAAP measure)3,4 $4.6 to $4.7 Adjusted free cash flow conversion (non-GAAP measure)4,5 >100% 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES – (CONTINUED) (Unaudited) 13 -- 13 of 15 -- Description of special items: In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides various non-GAAP measures that incorporate adjustments for the impacts of special items. Special items incorporated in the preparation of these non-GAAP measures for the periods presented include the items described below: Net costs for significant litigation: • These relate to 3M's respirator mask/asbestos (which include Aearo and non-Aearo items), PFAS-related other environmental, and Combat Arms Earplugs matters. Net costs include the impacts of changes in accrued liabilities (including interest imputation on applicable settlement obligations), legal costs, and insurance recoveries, along with the associated tax impacts. Associated tax impacts of significant litigation include impacts on Foreign Derived Intangible Income (FDII), Global Intangible Low Taxed Income (GILTI), foreign tax credits, and tax costs of repatriation. 3M does not consider the elements of the net costs associated with these matters to be normal, operating expenses related to the Company’s ongoing operations, revenue generating activities, business strategy, industry, and regulatory environment. Net costs related to respirator mask/asbestos are reflected as special items in the Safety and Industrial business segment while those impacting operating income (loss) associated with PFAS-related other environmental and Combat Arms Earplugs matters are reflected as corporate special items in Corporate and Other. In the fourth quarter of 2025 and 2024, 3M reflected net pre-tax cash (receipts)/payments of $181 million and $(17.0) million, respectively, related to net costs for significant litigation. In 2025 and 2024, 3M reflected net pre-tax cash (receipts)/payments of $3.5 billion and $4.5 billion, respectively, related to net costs for significant litigation. Loss on business divestitures: • In 2025, 3M reflected a net write-down for a business classified as held for sale and completed a divestiture for immaterial proceeds slightly below the business's book value. Divestiture costs and divestiture-related restructuring actions: • Divestiture costs include limited costs that were not eligible to be included within discontinued operations related to separating and divesting substantially an entire business segment of 3M following public announcement of its intended divestiture. As a result of completion of the April 2024 separation of Solventum, this includes the tax cost of updating 3M’s previous indefinite reinvestment plans on past unrepatriated earnings through the period of the Separation’s close and to tax positions retained by 3M. 3M’s statement of cash flows includes the results of both continuing and discontinued operations. Therefore, in the context of amounts used in the determination of non-GAAP measures associated with cash flow and adjusted free cash flow conversion, this special item further includes the broader extent of such costs included within discontinued operations, including interest expense on debt issued by Solventum for the period outstanding prior to the April 1, 2024 completion of the separation of Solventum from 3M and net tax costs of entity structuring associated with the separation of Solventum. In the fourth quarter and full year 2024, 3M made pre-tax cash payments of $28 million and $245 million, respectively, associated with divestiture costs. Divestiture-related restructuring relates to actions undertaken following the 2022 split-off of the Food Safety business to address corporate functional costs across 3M in relation to the magnitude of amounts previously allocated to the divested business. In 2024, 3M made pre-tax cash payments of $2 million associated with these actions. Enactment/measurement period adjustments related to the Tax Cuts and Jobs Act (TCJA): • In 2025 and 2024, 3M made payments of $211 million and $193 million, respectively, related to the transition tax expense incurred as a result of the 2017 enactment of the TCJA. Manufactured PFAS products: • These amounts relate to sales and estimates of income (loss) and associated activity regarding manufactured PFAS products that 3M exited by the end of 2025, included within the Transportation and Electronics business segment. Estimated income does not contemplate impacts on non-operating items such as net interest income/expense and the non- service cost components portion of defined benefit plan net periodic benefit costs. Relative to the impact of the activity of manufactured PFAS products on cash provided by (used in) operating activities, amounts are based on estimates of associated income, depreciation/amortization, certain changes in working capital and accruals, and timing of associated payments. Pension risk transfer charge: • In 2024, 3M recorded a non-cash pension settlement charge reflected in other expense (income), net as a result of transferring a portion of its U.S. pension payment obligations and related plan assets to an insurance company. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES – (CONTINUED) (Unaudited) 14 -- 14 of 15 -- Solventum ownership - change in value: • This amount relates to the change in value of 3M's retained ownership interest in Solventum common stock reflected in other expense (income), net. Transformation costs: • These represent net costs associated with 3M's transformation program, intended as a structural redesign of longer-term manufacturing, distribution, and business process services and locations. Accordingly, 3M does not consider the nature or effect of this program to be normal, operating expenses related to the Company’s ongoing operations, revenue generating activities, and day-to-day business strategy. Net costs include restructuring and other related items such as site closure, sale, moving and set-up, accelerated depreciation, and program management. In the fourth quarter and full year 2025, 3M made pre-tax cash payments of $14 million associated with transformation costs. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES – (CONTINUED) (Unaudited) 15 -- 15 of 15 --